These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3324934)

  • 1. Perspectives for the chemotherapy of AIDS.
    De Clercq E
    Anticancer Res; 1987; 7(5B):1023-38. PubMed ID: 3324934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives for the chemotherapy of AIDS.
    De Clercq E
    Chemioterapia; 1988 Dec; 7(6):357-64. PubMed ID: 2905940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic approaches to human immunodeficiency virus infections.
    Baba M
    Fukushima J Med Sci; 1992 Jun; 38(1):1-18. PubMed ID: 1284048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.
    Yarchoan R; Broder S
    N Engl J Med; 1987 Feb; 316(9):557-64. PubMed ID: 3543683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New perspectives for the chemotherapy and chemoprophylaxis of AIDS (acquired immune deficiency syndrome).
    De Clercq E
    Verh K Acad Geneeskd Belg; 1992; 54(1):57-88; discussion 88-9. PubMed ID: 1636322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiretroviral therapy of acquired immunodeficiency syndrome (AIDS)].
    Jevtović Dj; Ranin J; Salemović D; Brmbolić B; Zerjav S
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():38-41. PubMed ID: 18170976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Perspectives in AIDS chemotherapy].
    de Clercq E
    Cas Lek Cesk; 1989 Mar; 128(13):385-91. PubMed ID: 2571416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative enzymatic study of HIV-1 reverse transcriptase resistant to 2',3'-dideoxynucleotide analogs using the single-nucleotide incorporation assay.
    Ueno T; Mitsuya H
    Biochemistry; 1997 Feb; 36(5):1092-9. PubMed ID: 9033399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.
    Hao Z; Cooney DA; Hartman NR; Perno CF; Fridland A; DeVico AL; Sarngadharan MG; Broder S; Johns DG
    Mol Pharmacol; 1988 Oct; 34(4):431-5. PubMed ID: 2459590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
    De Clercq E
    Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine.
    Sachs MK
    Arch Intern Med; 1992 Mar; 152(3):485-501. PubMed ID: 1546911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral agents that act in the early phases of the viral cycle].
    Damonte EB
    Rev Argent Microbiol; 1996; 28(4):204-16. PubMed ID: 9102661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly synthesized L-enantiomers of 3'-fluoro-modified beta-2'-deoxyribonucleoside 5'-triphosphates inhibit hepatitis B DNA polymerases but not the five cellular DNA polymerases alpha, beta, gamma, delta, and epsilon nor HIV-1 reverse transcriptase.
    von Janta-Lipinski M; Costisella B; Ochs H; Hübscher U; Hafkemeyer P; Matthes E
    J Med Chem; 1998 Jun; 41(12):2040-6. PubMed ID: 9622545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase.
    Boyle NA; Rajwanshi VK; Prhavc M; Wang G; Fagan P; Chen F; Ewing GJ; Brooks JL; Hurd T; Leeds JM; Bruice TW; Cook PD
    J Med Chem; 2005 Apr; 48(7):2695-700. PubMed ID: 15801860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and anti-retroviral activity of various new 2',3'-dideoxynucleoside analogs].
    Van Aerschot A
    Verh K Acad Geneeskd Belg; 1991; 53(4):387-418. PubMed ID: 1719712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular virology founded models of anti-HIV therapy].
    Schröder HC; Müller WE
    Fortschr Med; 1994 Nov; 112(31):438-43. PubMed ID: 7528706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential drugs for the treatment of AIDS.
    De Clercq E
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():35-46. PubMed ID: 2654114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.